All Exams Test series for 1 year @ ₹349 only
Question

Which one of the following Indian institutes was approved by the Drugs Controller General of India for conducting human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate?

This question was previously asked in
CDS I 2020 Elementary Mathematics Previous Year Paper (02-Feb-2020)
The correct answer is

Serum Institute of India

Indian Institute Approved for Oxford-AstraZeneca Covid-19 Vaccine Trials

The question asks to identify the Indian institute that received approval from the Drugs Controller General of India (DCGI) to conduct human trials for the Oxford-AstraZeneca Covid-19 vaccine candidate.

Conducting human trials is a critical step in vaccine development. It involves testing the safety and effectiveness of a potential vaccine in people before it can be approved for widespread use. In India, this process is overseen by the DCGI.

Analyzing the Options for Vaccine Trial Approval

Let's look at the provided options:

  • Bharat Biotech: This is a well-known Indian biotechnology company. They developed India's first indigenous COVID-19 vaccine, Covaxin, in collaboration with ICMR-NIV. While they conduct clinical trials, they were primarily associated with Covaxin trials, not the Oxford-AstraZeneca vaccine trials in India.
  • AIIMS (All India Institute of Medical Sciences): AIIMS is a group of premier public medical colleges and research universities. Various AIIMS centers might serve as trial sites for different vaccines, but an AIIMS itself is not the primary institute *approved* by DCGI to *conduct* the overall human trials for a specific candidate like the Oxford-AstraZeneca one in the sense of leading the study and manufacturing process collaboration.
  • Serum Institute of India (SII): This is the world's largest vaccine manufacturer by volume. SII collaborated with Oxford University and AstraZeneca for manufacturing and conducting clinical trials of their vaccine candidate in India. SII sought and received approval from the DCGI for these trials.
  • National Institute of Epidemiology (NIE): This is a research institution focused on public health, epidemiology, and disease control. While they play a crucial role in epidemiological studies and public health guidance, they are not typically the institution leading the *clinical trials* or manufacturing partnership for a specific vaccine candidate like the one in question.

Serum Institute of India's Role in Oxford-AstraZeneca Vaccine Trials

The Serum Institute of India (SII), based in Pune, entered into a partnership with AstraZeneca to manufacture and supply the Oxford University-developed COVID-19 vaccine (later known as Covishield in India). As part of this collaboration, SII was responsible for conducting clinical trials in India to evaluate the vaccine's safety and efficacy on the Indian population.

The Drugs Controller General of India (DCGI), which is the regulatory authority for pharmaceuticals and medical devices in India, granted approval to the Serum Institute of India to conduct the necessary human trials for the Oxford-AstraZeneca vaccine candidate in the country.

Therefore, the Serum Institute of India was the specific Indian institute approved by the DCGI for leading the human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate.

Comparison of Institutes and Vaccine Roles
Institute Primary Role in Covid-19 Vaccines (Examples) Involved with Oxford-AstraZeneca Vaccine Trials in India?
Bharat Biotech Developed Covaxin (Indigenous vaccine) No (involved with Covaxin trials)
AIIMS Potential clinical trial sites Likely trial site, but not lead institute for this vaccine's DCGI approval
Serum Institute of India Manufactured & led trials for Oxford-AstraZeneca vaccine (Covishield) Yes (Approved by DCGI)
National Institute of Epidemiology Public health research, epidemiology studies No (not the lead institution for clinical trials)

Conclusion

Based on the roles of these institutions in India's response to the Covid-19 pandemic and vaccine development efforts, the Serum Institute of India was the entity that partnered with Oxford-AstraZeneca and received DCGI approval to conduct the necessary human trials in India.

Revision Table: Key Institutes and Covid-19 Vaccines

Organization Key Contribution (Covid-19 Vaccines)
Serum Institute of India (SII) Manufacturing and trials of Oxford-AstraZeneca vaccine (Covishield)
Bharat Biotech Development and trials of Covaxin
Drugs Controller General of India (DCGI) Regulatory approval for vaccines and trials in India
Oxford University / AstraZeneca Developer of the vaccine candidate

Additional Information: DCGI and Vaccine Trials in India

The Drugs Controller General of India (DCGI) is a crucial authority under the Central Drugs Standard Control Organization (CDSCO). Its main function is regulating pharmaceutical and medical devices, including approving licenses for new drugs, clinical trials, and vaccines in India. Any vaccine candidate developed domestically or internationally must undergo clinical trials in India and receive DCGI approval before it can be administered to the public.

The collaboration between international developers like Oxford-AstraZeneca and large Indian manufacturers like Serum Institute of India was vital for scaling up vaccine production and ensuring availability not just in India but globally. This partnership highlights India's significant capacity in vaccine manufacturing.

Was this answer helpful?

Similar Questions

  1. Which butterfly species was recently named the official butterfly of Jammu and Kashmir?

  2. In how many phases was the general election 2019 conducted in India?

  3. Which one of the following intellectual property rights is protected without making any registration?

  4. Which one of the following units is not a part of All India Radio's Transcription and Programme Exchange Service ?

  5. Which one among the following correctly represents the theme on which the interiors of the new Parliament Building is based?

    Lok Sabha

    Rajya Sabha

    (a)

    Lotus

    Banyan

    (b) 

    Peacock

    Lotus

    (c)

    Peacock

    Banyan

    (d)

    Lotus

    Peacock

  6. The theme of India’s G20 Presidency 'Vasudhaiva Kutumbakam’ or ‘One Earth-One Family-One Future’ is drawn from the  

  7. Which one of the following is the first State in India to have 100 percent households with tap water connection?

  8. Consider the following statements :

    The Government is promoting the 'Kisan Drone' for

    1. Spraying weedicides.

    2. Digitisation of land records.

    3. Crop assessment.

    Which of the statements given above is/are correct?

  9. Under which one of the following rivers has India's first underwater metro rail tunnel been constructed?

  10. A new species of pit-viper was discovered in 2019 and named after the State in which it was found. Identify the State from among the following:


Important Questions from National Affairs

  1. Since the launch of Pradhan Mantri MUDRA Yojana, how much per cent of loans have been given to women entrepreneurs?

  2. As announced in the Budget 2021, to promote seaweed cultivation, Govt. will establish Multipurpose Seaweed Park in ___________ by Indian Government.

  3. Which organization has launched a new technology 'Swastik' to disinfect water using natural oils?

  4. Which one of the following is an important social indicator to measure the extent of equality between men and women in a society, at a given point of time?

  5. As on March 2020, India comprises twenty-eight states and ______ union territories.

Need Expert Advice?
Test Series
CDS img
Defence
UPSC CDS 2026 Mock Test Series
536 Tests 4 Tests Free
1628 Attempts
4.3(173)
English, Hindi
More Questions from CDS

Start Your Preparation with Prepp Mobile App

Download the app from Google Play & App Store
Download the app from Google Play & App Store
Prepp Mobile App